|
Volumn 35, Issue 1, 2003, Pages 342-344
|
Advances in hepatitis B virus infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ANTIVIRUS AGENT;
CLEVUDINE;
DIAMINOPURINE DIOXOLANE;
EMTRICITABINE;
ENTECAVIR;
FAMCICLOVIR;
HEPATITIS B ANTIBODY;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B(E) ANTIGEN;
INTERFERON;
LAMIVUDINE;
LOBUCAVIR;
NUCLEOSIDE ANALOG;
PREDNISONE;
UNCLASSIFIED DRUG;
ANTIBODY RESPONSE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE COURSE;
DRUG SENSITIVITY;
GENOTYPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNE RESPONSE;
LIVER CARCINOGENESIS;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER FUNCTION;
LIVER GRAFT;
LIVER TRANSPLANTATION;
ORGAN DONOR;
PATHOLOGY;
PRIORITY JOURNAL;
RECIPIENT;
RECURRENT DISEASE;
SEROCONVERSION;
SEROLOGY;
VIRUS LOAD;
VIRUS MUTATION;
VIRUS REACTIVATION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
|
EID: 0037322504
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03996-9 Document Type: Conference Paper |
Times cited : (3)
|
References (33)
|